Safety of Arthritis Drugs, Day 2, Part 1

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food… read more

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial testing of the class of drugs, the review process at the FDA, and the medical issues in question. They also responded to questions from members of the committee.

A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close

People in this video

  • Steven Abramson Chairman New York University Medical School->Rheumatology
  • Joan Bathon Professor Johns Hopkins University->Medical School
  • Dennis Boulware Professor University of Alabama, Birmingham->Medicine
  • Byron Cryer M.D. Professor University of Texas at Dallas->Southwestern Medical School
  • Ralph D'Agostino Professor Boston University->Public Health and Statistics
  • Ruth Day Senior Fellow Duke University->Aging Center
  • John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
  • Thomas Fleming Chairman University of Washington->Biostatistics
  • Lawrence Friedman Official National Institutes of Health
  • Allan Gibofsky Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
  • David Graham Medical Officer U.S. Food and Drug Administration->Pharmaceutical Science
  • Charles Hennekens Professor University of Miami->School of Medicine
  • Louis Morris President Louis A. Morris and Associates
  • Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
  • Robert O'Neil Director U.S. Food and Drug Administration->Biostatistics
  • Richard Platt Professor Harvard University->Medical School
  • Steven Schafer Professor Stanford University->School of Medicine
  • Annette Stemhagen Official Covance Periapproval Services
  • Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
  • Kimberly Topper Executive Secretary U.S. Food and Drug Administration->Center for Drug Evaluation and Research
  • Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 2,

More Videos
More information about

Safety of Arthritis Drugs, Day 2, Part 1

78 Views
Program ID:
185588-1
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 18, 2005
Last Aired:
Feb 24, 2005

Airing Details

  • Feb 18, 2005 | 5:39am EST | C-SPAN 2
  • Feb 18, 2005 | 11:48am EST | C-SPAN 2
  • Feb 24, 2005 | 9:30am EST | C-SPAN 2
Purchase a DVD or Download

Safety of Arthritis Drugs, Day 2, Part 1

  • DVD
    Length:
    02:36:11
    Price:
    $29.95
    Add to Cart
  • MP3 audio
    Length:
    02:36:11
    Price:
    $0.99
    Add to Cart

Clips from This Video